🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Colorectal cancer is the third most frequent neoplasm after prostate and lu...
Status
Unknown
Location
SSD-Terapie Innovative Metastasi Addominali, Dipartimento di Oncologia Addominale, Istituto Nazionale Tumori di Napoli, IRCCS "G. Pascale".
Start Date
2020-05-11
Trial ID
NCT04397601
Treatments Being Tested
The primary objective of the two phase PERMAD trial is the evaluation of th...
Status
Unknown
Location
University Medical Center Hamburg-Eppendorf
Start Date
2015-03
Trial ID
NCT02331927
Treatments Being Tested
The primary objective is to determine the dose of aflibercept to be further...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2009-06
Trial ID
NCT00921661
Treatments Being Tested
Primary Objective: To provide metastatic colorectal cancer participants wi...
Status
Completed
Location
Investigational Site Number 840-002
Start Date
2012-05-30
Trial ID
NCT01571284
Treatments Being Tested
Immune chekpoints (ICI) are evaluated in many digestive cancers. Certain ty...
Status
Completed
Location
Ch - Centre Hospitalier D'Abbeville
Start Date
2018-04-24
Trial ID
NCT03186326
Treatments Being Tested
The PULSAR trial is an international, investigator-initiated, single arm op...
Status
Terminated
Location
Institut Bergonié
Start Date
2014-07
Trial ID
NCT02173990
Treatments Being Tested
Primary Objective: To evaluate the safety of aflibercept in participants w...
Status
Completed
Location
Administrative office
Start Date
2012-08
Trial ID
NCT01670721
Treatments Being Tested
Primary objective \- Evaluate the efficacy in terms of progression-free su...
Status
Completed
Location
Institut Sainte-Catherine
Start Date
2017-11-08
Trial ID
NCT03730558
Treatments Being Tested
Primary Objective: To assess the safety and pharmacokinetics preliminarily...
Status
Completed
Location
Investigational Site Number 156002
Start Date
2013-09
Trial ID
NCT01930552
Treatments Being Tested
Primary Objective: To assess efficacy aflibercept + 5-fluorouracil (5-FU)/...
Status
Completed
Location
Investigational Site Number 392011
Start Date
2013-07
Trial ID
NCT01882868
Treatments Being Tested